ReviewFrontiers in pharmacology2026
The impact of garlic and its active metabolites on degenerative musculoskeletal diseases.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the accelerating global population aging, the incidence of degenerative musculoskeletal diseases (such as osteoarthritis, osteoporosis, intervertebral disc degeneration and sarcopenia) continues to rise, posing a significant public health challenge. Current conventional therapeutic approaches, while alleviating symptoms, are often accompanied by side effects and struggle to reverse the pathological process. Garlic and its various active metabolites (such as allicin, S-allylmercaptocysteine, diallyl sulfide and diallyl disulfide, etc.) have been confirmed to possess multiple biological activities, including anti-inflammatory, antioxidant effects, regulation of signaling pathways, and maintenance of extracellular matrix homeostasis. Numerous studies have demonstrated that the active metabolites of garlic can intervene in degenerative musculoskeletal diseases by regulating multiple signaling pathways such as PI3K/Akt/NF-κB, RANKL/RANK/OPG, Wnt/β-catenin, and Akt/mTOR, significantly delaying the progression of the diseases. Therefore, this review summarizes the regulatory effects and potential mechanisms of garlic and its bioactive metabolites on degenerative musculoskeletal diseases, aiming to provide a scientific basis for the further development of adjunctive therapeutic strategies based on garlic active metabolites.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.